img

Global Acquired hemophilia A Drugs Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Acquired hemophilia A Drugs Market Insights, Forecast to 2034

ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer.
Global Acquired hemophilia A Drugs market is expected to reach to US$ 1207 million in 2024, with a positive growth of %, compared with US$ 1245 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Acquired hemophilia A Drugs industry is evaluated to reach US$ 996.1 million in 2029. The CAGR will be -3.2% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Acquired hemophilia A Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Acquired hemophilia A Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
Sobi
Segment by Type
200IU
250IU

Segment by Application


Hospital
Pharmacy

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Acquired hemophilia A Drugs plant distribution, commercial date of Acquired hemophilia A Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Acquired hemophilia A Drugs introduction, etc. Acquired hemophilia A Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Acquired hemophilia A Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Acquired hemophilia A Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Acquired hemophilia A Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 200IU
1.2.3 250IU
1.3 Market by Application
1.3.1 Global Acquired hemophilia A Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Acquired hemophilia A Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Acquired hemophilia A Drugs Revenue by Region
2.2.1 Global Acquired hemophilia A Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Acquired hemophilia A Drugs Revenue by Region (2018-2024)
2.2.3 Global Acquired hemophilia A Drugs Revenue by Region (2024-2029)
2.2.4 Global Acquired hemophilia A Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Acquired hemophilia A Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Acquired hemophilia A Drugs Sales by Region
2.4.1 Global Acquired hemophilia A Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Acquired hemophilia A Drugs Sales by Region (2018-2024)
2.4.3 Global Acquired hemophilia A Drugs Sales by Region (2024-2029)
2.4.4 Global Acquired hemophilia A Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Acquired hemophilia A Drugs Sales by Manufacturers
3.1.1 Global Acquired hemophilia A Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Acquired hemophilia A Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Acquired hemophilia A Drugs in 2022
3.2 Global Acquired hemophilia A Drugs Revenue by Manufacturers
3.2.1 Global Acquired hemophilia A Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Acquired hemophilia A Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Acquired hemophilia A Drugs Revenue in 2022
3.3 Global Key Players of Acquired hemophilia A Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Acquired hemophilia A Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Acquired hemophilia A Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Acquired hemophilia A Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Acquired hemophilia A Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Acquired hemophilia A Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Acquired hemophilia A Drugs Sales by Type
4.1.1 Global Acquired hemophilia A Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Acquired hemophilia A Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Acquired hemophilia A Drugs Sales Market Share by Type (2018-2029)
4.2 Global Acquired hemophilia A Drugs Revenue by Type
4.2.1 Global Acquired hemophilia A Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Acquired hemophilia A Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Acquired hemophilia A Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Acquired hemophilia A Drugs Price by Type
4.3.1 Global Acquired hemophilia A Drugs Price by Type (2018-2024)
4.3.2 Global Acquired hemophilia A Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Acquired hemophilia A Drugs Sales by Application
5.1.1 Global Acquired hemophilia A Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Acquired hemophilia A Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Acquired hemophilia A Drugs Sales Market Share by Application (2018-2029)
5.2 Global Acquired hemophilia A Drugs Revenue by Application
5.2.1 Global Acquired hemophilia A Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Acquired hemophilia A Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Acquired hemophilia A Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Acquired hemophilia A Drugs Price by Application
5.3.1 Global Acquired hemophilia A Drugs Price by Application (2018-2024)
5.3.2 Global Acquired hemophilia A Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Acquired hemophilia A Drugs Market Size by Type
6.1.1 US & Canada Acquired hemophilia A Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Acquired hemophilia A Drugs Revenue by Type (2018-2029)
6.2 US & Canada Acquired hemophilia A Drugs Market Size by Application
6.2.1 US & Canada Acquired hemophilia A Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Acquired hemophilia A Drugs Revenue by Application (2018-2029)
6.3 US & Canada Acquired hemophilia A Drugs Market Size by Country
6.3.1 US & Canada Acquired hemophilia A Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Acquired hemophilia A Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Acquired hemophilia A Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Acquired hemophilia A Drugs Market Size by Type
7.1.1 Europe Acquired hemophilia A Drugs Sales by Type (2018-2029)
7.1.2 Europe Acquired hemophilia A Drugs Revenue by Type (2018-2029)
7.2 Europe Acquired hemophilia A Drugs Market Size by Application
7.2.1 Europe Acquired hemophilia A Drugs Sales by Application (2018-2029)
7.2.2 Europe Acquired hemophilia A Drugs Revenue by Application (2018-2029)
7.3 Europe Acquired hemophilia A Drugs Market Size by Country
7.3.1 Europe Acquired hemophilia A Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Acquired hemophilia A Drugs Sales by Country (2018-2029)
7.3.3 Europe Acquired hemophilia A Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Acquired hemophilia A Drugs Market Size
8.1.1 China Acquired hemophilia A Drugs Sales (2018-2029)
8.1.2 China Acquired hemophilia A Drugs Revenue (2018-2029)
8.2 China Acquired hemophilia A Drugs Market Size by Application
8.2.1 China Acquired hemophilia A Drugs Sales by Application (2018-2029)
8.2.2 China Acquired hemophilia A Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Acquired hemophilia A Drugs Market Size by Type
9.1.1 Asia Acquired hemophilia A Drugs Sales by Type (2018-2029)
9.1.2 Asia Acquired hemophilia A Drugs Revenue by Type (2018-2029)
9.2 Asia Acquired hemophilia A Drugs Market Size by Application
9.2.1 Asia Acquired hemophilia A Drugs Sales by Application (2018-2029)
9.2.2 Asia Acquired hemophilia A Drugs Revenue by Application (2018-2029)
9.3 Asia Acquired hemophilia A Drugs Sales by Region
9.3.1 Asia Acquired hemophilia A Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Acquired hemophilia A Drugs Revenue by Region (2018-2029)
9.3.3 Asia Acquired hemophilia A Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Acquired hemophilia A Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Acquired hemophilia A Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Acquired hemophilia A Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi Acquired hemophilia A Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Sobi
11.2.1 Sobi Company Information
11.2.2 Sobi Overview
11.2.3 Sobi Acquired hemophilia A Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sobi Acquired hemophilia A Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sobi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Acquired hemophilia A Drugs Industry Chain Analysis
12.2 Acquired hemophilia A Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Acquired hemophilia A Drugs Production Mode & Process
12.4 Acquired hemophilia A Drugs Sales and Marketing
12.4.1 Acquired hemophilia A Drugs Sales Channels
12.4.2 Acquired hemophilia A Drugs Distributors
12.5 Acquired hemophilia A Drugs Customers
13 Market Dynamics
13.1 Acquired hemophilia A Drugs Industry Trends
13.2 Acquired hemophilia A Drugs Market Drivers
13.3 Acquired hemophilia A Drugs Market Challenges
13.4 Acquired hemophilia A Drugs Market Restraints
14 Key Findings in The Global Acquired hemophilia A Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Acquired hemophilia A Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 200IU
Table 3. Major Manufacturers of 250IU
Table 4. Global Acquired hemophilia A Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Acquired hemophilia A Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Acquired hemophilia A Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Acquired hemophilia A Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Acquired hemophilia A Drugs Revenue Market Share by Region (2018-2024)
Table 9. Global Acquired hemophilia A Drugs Revenue Market Share by Region (2024-2029)
Table 10. Global Acquired hemophilia A Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Acquired hemophilia A Drugs Sales by Region (2018-2024) & (K Units)
Table 12. Global Acquired hemophilia A Drugs Sales by Region (2024-2029) & (K Units)
Table 13. Global Acquired hemophilia A Drugs Sales Market Share by Region (2018-2024)
Table 14. Global Acquired hemophilia A Drugs Sales Market Share by Region (2024-2029)
Table 15. Global Acquired hemophilia A Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Acquired hemophilia A Drugs Sales Share by Manufacturers (2018-2024)
Table 17. Global Acquired hemophilia A Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Acquired hemophilia A Drugs Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Acquired hemophilia A Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Acquired hemophilia A Drugs Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Acquired hemophilia A Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Acquired hemophilia A Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired hemophilia A Drugs as of 2022)
Table 23. Global Key Manufacturers of Acquired hemophilia A Drugs, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Acquired hemophilia A Drugs, Product Offered and Application
Table 25. Global Key Manufacturers of Acquired hemophilia A Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Acquired hemophilia A Drugs Sales by Type (2018-2024) & (K Units)
Table 28. Global Acquired hemophilia A Drugs Sales by Type (2024-2029) & (K Units)
Table 29. Global Acquired hemophilia A Drugs Sales Share by Type (2018-2024)
Table 30. Global Acquired hemophilia A Drugs Sales Share by Type (2024-2029)
Table 31. Global Acquired hemophilia A Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Acquired hemophilia A Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Acquired hemophilia A Drugs Revenue Share by Type (2018-2024)
Table 34. Global Acquired hemophilia A Drugs Revenue Share by Type (2024-2029)
Table 35. Acquired hemophilia A Drugs Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Acquired hemophilia A Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Acquired hemophilia A Drugs Sales by Application (2018-2024) & (K Units)
Table 38. Global Acquired hemophilia A Drugs Sales by Application (2024-2029) & (K Units)
Table 39. Global Acquired hemophilia A Drugs Sales Share by Application (2018-2024)
Table 40. Global Acquired hemophilia A Drugs Sales Share by Application (2024-2029)
Table 41. Global Acquired hemophilia A Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Acquired hemophilia A Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Acquired hemophilia A Drugs Revenue Share by Application (2018-2024)
Table 44. Global Acquired hemophilia A Drugs Revenue Share by Application (2024-2029)
Table 45. Acquired hemophilia A Drugs Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Acquired hemophilia A Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Acquired hemophilia A Drugs Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Acquired hemophilia A Drugs Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Acquired hemophilia A Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Acquired hemophilia A Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Acquired hemophilia A Drugs Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Acquired hemophilia A Drugs Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Acquired hemophilia A Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Acquired hemophilia A Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Acquired hemophilia A Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Acquired hemophilia A Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Acquired hemophilia A Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Acquired hemophilia A Drugs Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Acquired hemophilia A Drugs Sales by Country (2024-2029) & (K Units)
Table 60. Europe Acquired hemophilia A Drugs Sales by Type (2018-2024) & (K Units)
Table 61. Europe Acquired hemophilia A Drugs Sales by Type (2024-2029) & (K Units)
Table 62. Europe Acquired hemophilia A Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Acquired hemophilia A Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Acquired hemophilia A Drugs Sales by Application (2018-2024) & (K Units)
Table 65. Europe Acquired hemophilia A Drugs Sales by Application (2024-2029) & (K Units)
Table 66. Europe Acquired hemophilia A Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Acquired hemophilia A Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Acquired hemophilia A Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Acquired hemophilia A Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Acquired hemophilia A Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Acquired hemophilia A Drugs Sales by Country (2018-2024) & (K Units)
Table 72. Europe Acquired hemophilia A Drugs Sales by Country (2024-2029) & (K Units)
Table 73. China Acquired hemophilia A Drugs Sales by Type (2018-2024) & (K Units)
Table 74. China Acquired hemophilia A Drugs Sales by Type (2024-2029) & (K Units)
Table 75. China Acquired hemophilia A Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Acquired hemophilia A Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Acquired hemophilia A Drugs Sales by Application (2018-2024) & (K Units)
Table 78. China Acquired hemophilia A Drugs Sales by Application (2024-2029) & (K Units)
Table 79. China Acquired hemophilia A Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Acquired hemophilia A Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Acquired hemophilia A Drugs Sales by Type (2018-2024) & (K Units)
Table 82. Asia Acquired hemophilia A Drugs Sales by Type (2024-2029) & (K Units)
Table 83. Asia Acquired hemophilia A Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Acquired hemophilia A Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Acquired hemophilia A Drugs Sales by Application (2018-2024) & (K Units)
Table 86. Asia Acquired hemophilia A Drugs Sales by Application (2024-2029) & (K Units)
Table 87. Asia Acquired hemophilia A Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Acquired hemophilia A Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Acquired hemophilia A Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Acquired hemophilia A Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Acquired hemophilia A Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Acquired hemophilia A Drugs Sales by Region (2018-2024) & (K Units)
Table 93. Asia Acquired hemophilia A Drugs Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales by Country (2024-2029) & (K Units)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Acquired hemophilia A Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Acquired hemophilia A Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. Sobi Company Information
Table 113. Sobi Description and Major Businesses
Table 114. Sobi Acquired hemophilia A Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Sobi Acquired hemophilia A Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sobi Recent Developments
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Acquired hemophilia A Drugs Distributors List
Table 120. Acquired hemophilia A Drugs Customers List
Table 121. Acquired hemophilia A Drugs Market Trends
Table 122. Acquired hemophilia A Drugs Market Drivers
Table 123. Acquired hemophilia A Drugs Market Challenges
Table 124. Acquired hemophilia A Drugs Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Acquired hemophilia A Drugs Product Picture
Figure 2. Global Acquired hemophilia A Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Acquired hemophilia A Drugs Market Share by Type in 2022 & 2029
Figure 4. 200IU Product Picture
Figure 5. 250IU Product Picture
Figure 6. Global Acquired hemophilia A Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Acquired hemophilia A Drugs Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Acquired hemophilia A Drugs Report Years Considered
Figure 11. Global Acquired hemophilia A Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Acquired hemophilia A Drugs Revenue 2018-2029 (US$ Million)
Figure 13. Global Acquired hemophilia A Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Acquired hemophilia A Drugs Revenue Market Share by Region (2018-2029)
Figure 15. Global Acquired hemophilia A Drugs Sales 2018-2029 ((K Units)
Figure 16. Global Acquired hemophilia A Drugs Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Acquired hemophilia A Drugs Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Acquired hemophilia A Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Acquired hemophilia A Drugs Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Acquired hemophilia A Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Acquired hemophilia A Drugs Sales YoY (2018-2029) & (K Units)
Figure 22. China Acquired hemophilia A Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Acquired hemophilia A Drugs Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Acquired hemophilia A Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Acquired hemophilia A Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Acquired hemophilia A Drugs in the World: Market Share by Acquired hemophilia A Drugs Revenue in 2022
Figure 29. Global Acquired hemophilia A Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Acquired hemophilia A Drugs Sales Market Share by Type (2018-2029)
Figure 31. Global Acquired hemophilia A Drugs Revenue Market Share by Type (2018-2029)
Figure 32. Global Acquired hemophilia A Drugs Sales Market Share by Application (2018-2029)
Figure 33. Global Acquired hemophilia A Drugs Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Acquired hemophilia A Drugs Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Acquired hemophilia A Drugs Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Acquired hemophilia A Drugs Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Acquired hemophilia A Drugs Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Acquired hemophilia A Drugs Revenue Share by Country (2018-2029)
Figure 39. US & Canada Acquired hemophilia A Drugs Sales Share by Country (2018-2029)
Figure 40. U.S. Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Acquired hemophilia A Drugs Sales Market Share by Type (2018-2029)
Figure 43. Europe Acquired hemophilia A Drugs Revenue Market Share by Type (2018-2029)
Figure 44. Europe Acquired hemophilia A Drugs Sales Market Share by Application (2018-2029)
Figure 45. Europe Acquired hemophilia A Drugs Revenue Market Share by Application (2018-2029)
Figure 46. Europe Acquired hemophilia A Drugs Revenue Share by Country (2018-2029)
Figure 47. Europe Acquired hemophilia A Drugs Sales Share by Country (2018-2029)
Figure 48. Germany Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 49. France Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 50. UK Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. China Acquired hemophilia A Drugs Sales Market Share by Type (2018-2029)
Figure 54. China Acquired hemophilia A Drugs Revenue Market Share by Type (2018-2029)
Figure 55. China Acquired hemophilia A Drugs Sales Market Share by Application (2018-2029)
Figure 56. China Acquired hemophilia A Drugs Revenue Market Share by Application (2018-2029)
Figure 57. Asia Acquired hemophilia A Drugs Sales Market Share by Type (2018-2029)
Figure 58. Asia Acquired hemophilia A Drugs Revenue Market Share by Type (2018-2029)
Figure 59. Asia Acquired hemophilia A Drugs Sales Market Share by Application (2018-2029)
Figure 60. Asia Acquired hemophilia A Drugs Revenue Market Share by Application (2018-2029)
Figure 61. Asia Acquired hemophilia A Drugs Revenue Share by Region (2018-2029)
Figure 62. Asia Acquired hemophilia A Drugs Sales Share by Region (2018-2029)
Figure 63. Japan Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. India Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Acquired hemophilia A Drugs Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Acquired hemophilia A Drugs Sales Share by Country (2018-2029)
Figure 74. Brazil Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Acquired hemophilia A Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. Acquired hemophilia A Drugs Value Chain
Figure 80. Acquired hemophilia A Drugs Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed